Sublocade is an extended-release buprenorphine delivered for one month by which administration route?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

Sublocade is an extended-release buprenorphine delivered for one month by which administration route?

Explanation:
Depot-based, monthly extended-release delivery relies on a subcutaneous injection that forms a drug depot to release medication over time. Sublocade is designed to be given as a subcutaneous injection into the abdominal tissue, where the depot gradually releases buprenorphine over about a month. This route provides a steady level of the medication and avoids the rapid spikes or immediate systemic exposure seen with intravenous use or non-depot routes. A transdermal patch is a different delivery method and does not create the same monthly depot. Administering the injection into the abdomen ensures the depot forms properly for consistent release throughout the treatment period.

Depot-based, monthly extended-release delivery relies on a subcutaneous injection that forms a drug depot to release medication over time. Sublocade is designed to be given as a subcutaneous injection into the abdominal tissue, where the depot gradually releases buprenorphine over about a month. This route provides a steady level of the medication and avoids the rapid spikes or immediate systemic exposure seen with intravenous use or non-depot routes. A transdermal patch is a different delivery method and does not create the same monthly depot. Administering the injection into the abdomen ensures the depot forms properly for consistent release throughout the treatment period.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy